Lauren Merendino - 18 Oct 2022 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Chief Commercial Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Oct 2022
Net transactions value
-$42,916
Form type
4
Filing time
20 Oct 2022, 16:54:30 UTC
Previous filing
20 Jul 2022
Next filing
20 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $42,916 -1,703 -0.98% $25.20 171,546 18 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.